1. Home
  2. CORT vs BEP Comparison

CORT vs BEP Comparison

Compare CORT & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • BEP
  • Stock Information
  • Founded
  • CORT 1998
  • BEP 1999
  • Country
  • CORT United States
  • BEP Canada
  • Employees
  • CORT N/A
  • BEP N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • BEP Electric Utilities: Central
  • Sector
  • CORT Health Care
  • BEP Utilities
  • Exchange
  • CORT Nasdaq
  • BEP Nasdaq
  • Market Cap
  • CORT 7.6B
  • BEP 7.3B
  • IPO Year
  • CORT N/A
  • BEP N/A
  • Fundamental
  • Price
  • CORT $72.87
  • BEP $25.32
  • Analyst Decision
  • CORT Strong Buy
  • BEP Buy
  • Analyst Count
  • CORT 4
  • BEP 8
  • Target Price
  • CORT $139.00
  • BEP $31.25
  • AVG Volume (30 Days)
  • CORT 658.4K
  • BEP 428.2K
  • Earning Date
  • CORT 10-29-2025
  • BEP 11-07-2025
  • Dividend Yield
  • CORT N/A
  • BEP 5.82%
  • EPS Growth
  • CORT N/A
  • BEP N/A
  • EPS
  • CORT 1.11
  • BEP N/A
  • Revenue
  • CORT $716,080,000.00
  • BEP $6,174,000,000.00
  • Revenue This Year
  • CORT $30.62
  • BEP $18.12
  • Revenue Next Year
  • CORT $37.68
  • BEP $5.94
  • P/E Ratio
  • CORT $65.38
  • BEP N/A
  • Revenue Growth
  • CORT 25.71
  • BEP 12.75
  • 52 Week Low
  • CORT $35.45
  • BEP $19.29
  • 52 Week High
  • CORT $117.33
  • BEP $29.56
  • Technical
  • Relative Strength Index (RSI)
  • CORT 56.90
  • BEP 50.70
  • Support Level
  • CORT $67.32
  • BEP $24.48
  • Resistance Level
  • CORT $72.52
  • BEP $25.50
  • Average True Range (ATR)
  • CORT 2.19
  • BEP 0.43
  • MACD
  • CORT 0.36
  • BEP 0.05
  • Stochastic Oscillator
  • CORT 74.30
  • BEP 55.63

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About BEP Brookfield Renewable Partners L.P.

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.

Share on Social Networks: